Recognise the signs and symptoms of respiratory syncytial virus (RSV) as well as the risk that it poses to infants and children, plus how the new national immunisation programme will work
A national respiratory syncytial virus (RSV) vaccination programme for newborns and older or vulnerable adults starts soon, making the UK the world’s first nation to attempt such coverage.
Primary Health Care. 34, 5, 6-7. doi: 10.7748/phc.34.5.6.s2
or
Alternatively, you can purchase access to this article for the next seven days. Buy now
Are you a student? Our student subscription has content especially for you.
Find out more